Obstructive Lung Disease Companies

AstraZeneca Received FDA approval for their triple-therapy inhaler, Breztri Aerosolizer, for treating moderate-to-severe COPD patients, offering a convenient one-inhaler option for symptom control.Partnered with AI companies to develop algorithms for analyzing respiratory data and predicting exacerbations in COPD patients, enabling proactive interventions.

GlaxoSmithKline (GSK) Launched their next-generation inhaler, Trelegy Ellipta, in new markets for COPD treatment, offering a once-daily single inhaler option for improved adherence.Conducted clinical trials on their investigational inhaled corticosteroid/long-acting beta-agonist combination therapy for asthma, targeting specific inflammatory pathways for potentially improved symptom control.

Novartis Presented positive Phase III data for their inhaled IL-17 inhibitor, QMF149, for treating severe asthma, showcasing its potential to control inflammation and reduce exacerbations.Expanded their research efforts on gene therapy approaches for lung diseases like alpha-1 antitrypsin deficiency, a rare genetic form of COPD, aiming for curative solutions.

Teva Pharmaceuticals Unveiled their new digital inhaler platform, Digihaler™, with integrated sensors and a companion app, providing data on medication usage and allowing for personalized dose adjustments.Collaborated with patient advocacy groups to develop educational resources and support programs for individuals living with OLD, empowering them to manage their condition effectively.

Lung Foundation of India Launched a nationwide awareness campaign on COPD, emphasizing early diagnosis, risk factors, and treatment options, aiming to reach underserved communities.Provided funding for research initiatives investigating the prevalence and impact of OLD in India, guiding public health strategies and resource allocation.

List of Obstructive Lung Disease Key Companies in the Market

• GlaxoSmithKline (GSK) (U.K)


• Novartis AG (Switzerland)


• Merck & Co. Inc. (U.S)


• Abbott Laboratories (U.S)


• Boehringer Ingelheim (Germany)


• AstraZeneca (U.K)


• Roche Holding AG (Switzerland)


• Teva Pharmaceutical Industries (Israel)


• Vectura Group (U.K)


• Pfizer Inc. (U.S)


• Mylan (U.S.)


• Aerovance Inc. (U.S.)


• Alkermes Inc. (U.S.)


• Almirall SA. (U.S.)


• Genentech Inc. (U.S.)


• Sepracor, Inc. (U.S.)


• Skyepharma plc (U.S.)